Ads
related to: johnson- Latest news
See the latest news from J&J.
Company updates and more.
- Our leadership team
Meet the J&J Executive Committee
& our Board of Directors.
- Discover J&J
Learn about our strength
in healthcare innovation.
- The J&J Credo
Putting the needs of the
people we serve first.
- Latest news
Search results
Woman awarded $260M from Johnson & Johnson following cancer diagnosis
KY3 Springfield· 18 hours agoA woman in Oregon was recently awarded $260 million in a lawsuit against pharmaceutical giant ...
Tomball’s two-run sixth inning ends Johnson’s season
San Antonio Express-News· 8 hours agoWith the bases loaded and a full count, Johnson pitcher Tyler Walton faced a high-stakes test for the second consecutive inning. Tomball’s Blaine Lucas...
Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the...
Simply Wall St. via Yahoo Finance· 24 hours agoKey Insights Given the large stake in the stock by institutions,Johnson & Johnson's stock price...
Is Johnson & Johnson A Good Quality Stock to Buy Now?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled the list of the 13 Best Quality Stocks to Buy Now according to the hedge funds...
Cody Johnson: 'It's important to remember those that came before us'
The Tennessean via Yahoo News· 31 minutes agoCody Johnson talks with The Tennessean's Marcus K. Dowling ahead of his Nissan Stadium performance during CMA Fest Friday, June 8, 2024
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
Morningstar· 4 days agoJohnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, July 17th to review second-quarter results ...
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in...
The Tomahawk· 1 day agoToday, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, has ...
Is Johnson & Johnson (NYSE:JNJ) the Best Mega-Cap Dividend Aristocrat Stock?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since ...
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
Zacks· 3 days agoThe latest trading session saw Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) ending at $145.97, denoting a -1.24% adjustment from its last day's ...
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 17 hours agoJohnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering price on Friday, in a tepid debut for the early-stage therapy developer.
Ad
related to: johnson